| Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update SK Sarin, M Kumar, GK Lau, Z Abbas, HLY Chan, CJ Chen, DS Chen, ... Hepatology international 10, 1-98, 2016 | 2565 | 2016 |
| Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B GKK Lau, T Piratvisuth, KX Luo, P Marcellin, S Thongsawat, G Cooksley, ... New England Journal of Medicine 352 (26), 2682-2695, 2005 | 1984 | 2005 |
| Hepatitis B virus infection YF Liaw, CM Chu The lancet 373 (9663), 582-592, 2009 | 1687 | 2009 |
| Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B P Marcellin, GKK Lau, F Bonino, P Farci, S Hadziyannis, R Jin, ZM Lu, ... New England Journal of Medicine 351 (12), 1206-1217, 2004 | 1521 | 2004 |
| Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update YF Liaw, N Leung, JH Kao, T Piratvisuth, E Gane, KH Han, R Guan, ... Hepatology international 2, 263-283, 2008 | 1264 | 2008 |
| Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy B Werle–Lapostolle, S Bowden, S Locarnini, K Wursthorn, J Petersen, ... Gastroenterology 126 (7), 1750-1758, 2004 | 1192 | 2004 |
| Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) SK Sarin, A Kumar, JA Almeida, YK Chawla, ST Fan, H Garg, HJ de Silva, ... Hepatology international 3, 269-282, 2009 | 1066 | 2009 |
| Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use KC Lai, SK Lam, KM Chu, BCY Wong, WM Hui, WHC Hu, GKK Lau, ... New England Journal of Medicine 346 (26), 2033-2038, 2002 | 825 | 2002 |
| Silver nanoparticles inhibit hepatitis B virus replication L Lu, RWY Sun, R Chen, CK Hui, CM Ho, JM Luk, GKK Lau, CM Che Antiviral therapy 13 (2), 253-262, 2008 | 753 | 2008 |
| Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score D Ji, D Zhang, J Xu, Z Chen, T Yang, P Zhao, G Chen, G Cheng, Y Wang, ... Clinical Infectious Diseases 71 (6), 1393-1399, 2020 | 720 | 2020 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 703 | 2003 |
| Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update SK Sarin, A Choudhury, MK Sharma, R Maiwall, M Al Mahtab, S Rahman, ... Hepatology international 13, 353-390, 2019 | 675 | 2019 |
| Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B MR Brunetto, F Moriconi, F Bonino, GKK Lau, P Farci, C Yurdaydin, ... Hepatology 49 (4), 1141-1150, 2009 | 666 | 2009 |
| Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2005 update YF Liaw, N Leung, R Guan, GKK Lau, I Merican, G McCaughan, E Gane, ... Liver international 25 (3), 472-489, 2005 | 609 | 2005 |
| Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease RP Perrillo Gastroenterology 120 (4), 1009-1022, 2001 | 580 | 2001 |
| Kinetics and risk of de novo hepatitis B infection in HBsAg–negative patients undergoing cytotoxic chemotherapy CK Hui, WWW Cheung, HY Zhang, WY Au, YH Yueng, AYH Leung, ... Gastroenterology 131 (1), 59-68, 2006 | 572 | 2006 |
| Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary GC Farrell, S Chitturi, GKK Lau, JD Sollano, ... Journal of gastroenterology and hepatology 22 (6), 775-777, 2007 | 571 | 2007 |
| Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy GKK Lau, HHY Yiu, DYT Fong, HC Cheng, WY Au, LSF Lai, M Cheung, ... Gastroenterology 125 (6), 1742-1749, 2003 | 567 | 2003 |
| Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response HLY Chan, VWS Wong, AML Tse, CH Tse, AML Chim, HY Chan, ... Clinical Gastroenterology and Hepatology 5 (12), 1462-1468, 2007 | 552 | 2007 |
| Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers AJV Thompson, T Nguyen, D Iser, A Ayres, K Jackson, M Littlejohn, ... Hepatology 51 (6), 1933-1944, 2010 | 536 | 2010 |
